GST polymorphisms are associated with hepatocellular carcinoma risk in Chinese population

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 27

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

263

HTML

1816

Figures (1-4)

127

Tables (1-4)

169

Sum=2375

Jul 21, 2011 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jul 21, 2011; 17(27): 3248-3256
Published online Jul 21, 2011. doi: 10.3748/wjg.v17.i27.3248

Figure 1 Forest plot of the meta-analysis of the association between GSTM1 polymorphism and hepatocellular carcinoma risk.

Figure 2 Forest plot of the meta-analysis of the association between GSTT1 polymorphism and hepatocellular carcinoma risk.

Figure 3 Funnel plot of the meta-analysis of the association between GSTM1 polymorphism and hepatocellular carcinoma risk.

Figure 4 Funnel plot of the meta-analysis of the association between GSTT1 polymorphism and hepatocellular carcinoma risk.

Citation: Yu L, Wang CY, Xi B, Sun L, Wang RQ, Yan YK, Zhu LY. GST polymorphisms are associated with hepatocellular carcinoma risk in Chinese population. World J Gastroenterol 2011; 17(27): 3248-3256
URL: https://www.wjgnet.com/1007-9327/full/v17/i27/3248.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i27.3248